EXHIBIT 10.1 CELL THERAPEUTICS, INC. SERIES A CONVERTIBLE PREFERRED STOCK, without par value STOCK PURCHASE AGREEMENT _________________________Stock Purchase Agreement • November 14th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
EXHIBIT 10.5 EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the 17th day of December, 1996, by and between JAMES A. BIANCO, M.D. ("Employee"), and CELL THERAPEUTICS, INC., a Washington...Employment Agreement • January 31st, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
ARTICLE IVoting Agreement • June 26th, 2003 • Cell Therapeutics Inc • Pharmaceutical preparations • Delaware
EXHIBIT 4.2 CELL THERAPEUTICS, INC. FORM OF REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (the "Agreement") is made as of the 15th day of February, 2000, by and between Cell Therapeutics, Inc., a Washington corporation (the...Registration Rights Agreement • April 12th, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
3,130,435 Shares CELL THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • September 22nd, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
andRights Agreement • November 15th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
This Limited Liability Company Agreement (the "Operating Agreement") of ------------------- Cell City, LLC, a limited liability company organized pursuant to the Delaware Limited Liability Company Act, is entered into this 5th day of January, 1998 by...Limited Liability Company Agreement • May 15th, 1998 • Cell Therapeutics Inc • Pharmaceutical preparations • Delaware
FORM OF STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENTSeverance Agreement • January 31st, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
RECITALS --------Lease Agreement • January 31st, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations
ARTICLE IStock Purchase Agreement • March 17th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations
RECITALSRegistration Rights Agreement • November 14th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
ISDA(R)Master Agreement • March 29th, 2002 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Exhibit 10.1 LOAN AGREEMENTLoan Agreement • April 12th, 2002 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
RECITALSRegistration Rights Agreement • December 30th, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Exhibit 4.3 WARRANT NO. P-3 DATE OF ISSUANCE: November 24, 1999 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF CELL THERAPEUTICS, INC. This Warrant is issued to ("Purchaser") pursuant to that certain Securities Purchase Agreement dated as of November,...Cell Therapeutics Inc • December 30th, 1999 • Pharmaceutical preparations • New York
CELL THERAPEUTICS, INC., as Issuer STATE STREET BANK AND TRUST COMPANY OF CALIFORNIA, N.A., a national banking association, as Trustee INDENTURECell Therapeutics Inc • June 13th, 2001 • Pharmaceutical preparations • New York
20,000,000 Shares CTI BioPharma Corp. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2018 • Cti Biopharma Corp • Pharmaceutical preparations • New York
RECITALSSupply Agreement • March 17th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
EXHIBIT 10.2 CELL THERAPEUTICS, INC. SERIES A CONVERTIBLE PREFERRED STOCK, without par value STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 14th, 1996 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Exhibit 2.2 AMENDMENT NO. 1 TO MERGER AGREEMENT THIS AMENDMENT NO. 1 TO MERGER AGREEMENT (this "Amendment No. 1"), dated as of March 6, 2003, is being entered into by and among Cell Therapeutics, Inc. a Washington corporation ("CTI"), PolaRx...Merger Agreement • March 27th, 2003 • Cell Therapeutics Inc • Pharmaceutical preparations
Exhibit 1.1 3,000,000 Shares CELL THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • March 24th, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
INDEMNIFICATION AGREEMENTIndemnification Agreement • January 24th, 2018 • Cti Biopharma Corp • Pharmaceutical preparations • Delaware
This Indemnification Agreement ("Agreement"), dated as of the Effective Date, is entered by and between CTI BioPharma Corp., a Delaware corporation (the "Company"), and ______________ ("Indemnitee"). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
EXHIBIT 10.6 ELLIOTT BAY OFFICE PARK OFFICE LEASEOffice Lease • March 31st, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
Sublandlord and Subtenant hereby acknowledge and agree that Area 3 is currently subleased by Subtenant from Sublandlord pursuant to that certain Sublease dated December 4, 2000 (the "Prior Sublease"). Sublandlord and -------------- Subtenant agree...Sublease Agreement • April 30th, 2002 • Cell Therapeutics Inc • Pharmaceutical preparations
EXHIBIT 4.1 EXECUTION COPY -------------- SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the "Agreement") is entered into as of November 15, 1999 (the "Execution Date"), between Cell Therapeutics, Inc., a Washington corporation (the...Securities Purchase Agreement • December 30th, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions are marked ***** and have been filed separately with the Commission. LICENSE AGREEMENT dated as of November 13, 1998License Agreement • March 31st, 1999 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
ANDAgreement and Plan of Merger • June 26th, 2003 • Cell Therapeutics Inc • Pharmaceutical preparations • Delaware
EXHIBIT 4.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the "Agreement") is entered into as of February 15, 2000 (the "Execution Date"), between Cell Therapeutics, Inc., a Washington corporation (the "Company"), and the investors...Securities Purchase Agreement • April 12th, 2000 • Cell Therapeutics Inc • Pharmaceutical preparations • New York
CELL THERAPEUTICS, INC. AND [ ], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • February 15th, 2011 • Cell Therapeutics Inc • Pharmaceutical preparations
DEBT SECURITIES WARRANT AGREEMENT, dated as of [ ] between Cell Therapeutics, Inc., a Washington corporation (the “Company”) and [ ], a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in [ ], as warrant agent (the “Warrant Agent”).
OPEN MARKET SALE AGREEMENTSMCti Biopharma Corp • August 17th, 2022 • Pharmaceutical preparations • New York
CELL THERAPEUTICS, INC. and [ ], AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • February 15th, 2011 • Cell Therapeutics Inc • Pharmaceutical preparations
PREFERRED STOCK WARRANT AGREEMENT, dated as of [ ] between Cell Therapeutics, Inc., a Washington corporation (the “Company”) and [ ], a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in [ ], as warrant agent (the “Warrant Agent”).
AGREEMENT ---------Nonstatutory Stock Option Agreement • November 13th, 1997 • Cell Therapeutics Inc • Pharmaceutical preparations • Washington
Portions of this Exhibit have been omitted pursuant to a request for confidential treatment. The omitted portions are marked ***** and have been filed separately with the Commission.Exclusive License Agreement • May 15th, 1998 • Cell Therapeutics Inc • Pharmaceutical preparations • California
EXHIBIT 10.10 PROMISSORY NOTECell Therapeutics Inc • March 31st, 1999 • Pharmaceutical preparations
JOINT FILING AGREEMENTJoint Filing Agreement • January 28th, 2004 • Cell Therapeutics Inc • Pharmaceutical preparations
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
